Search Results 1181-1190 of 19349 for Hemoglobin

1. Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study - Mayo Clinic

   Hemoglobin (Hgb) < 9 g/dl; Renal replacement therapy; History of renal artery stenosis > 50%; Hemodynamically significant arrhythmias including ventricular ...

2. Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection - Mayo Clinic

   Uncontrolled diabetes, defined as hemoglobin A1c > 7.4%. BMI > 45; Any acute illness within 14 days of Day 1 that could confound the evaluation of safety ...

3. Lupus nephritis - Symptoms and causes - Mayo Clinic

   Lupus causes the immune system to make proteins called autoantibodies. These proteins attack tissues and organs in the body, including the kidneys.

4. Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment - Mayo Clinic

   Hemoglobin ≥9 g/dL;; Serum creatinine ≤1.5 x upper limit of normal (ULN) or calculated creatinine clearance ≥50 mL/min using Cockcroft-Gault equation ...

5. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   Hemoglobin < 10g /100 mL for male and < 9g/ 100 mL for female;; Platelets < 100 000/mm^3;; Creatinine ≥ 150 μmol/L. Patients on macrolide (e.g., azithromycin) ...

6. A Study in Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab vs. Observation - Mayo Clinic

   Hemoglobin >= 9.0 g/dL, within 4 weeks of randomization. Serum creatinine =< 1.5 x upper limit of normal (ULN) or calculated creatinine clearance (CrCl) ...

7. CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study - Mayo Clinic

   Hemoglobin < 8.5 gm/dl; Other acute or chronic medical conditions or laboratory abnormality which may increase the risks associated with study participation ...

8. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (red blood cell transfusion and erythropoietin may be used to reach 9 g/dL but must have been administered at least 2 weeks prior to ...

9. Benzocaine (oral route, oromucosal route) - Side effects & dosage - Mayo Clinic

   Hereditary metabolic disorder affecting red blood cells (eg, G6PD deficiency, hemoglobin-M disease, NADH-methemoglobin reductase deficiency, pyruvate-kinase ...

10. Hyperbaric oxygen therapy - Mayo Clinic

    This type of therapy is a well-known treatment for decompression sickness, but it has other uses. Find out about why and how oxygen may help heal the body.